Quick Summary
In this meta-analysis of prospective observational studies, adults with chronic kidney disease who fasted for Ramadan did not have changes in their levels of blood lipids, uric acid, or HbA1c.
What was studied?
The association between Ramadan fasting and changes in the levels of blood lipids (total cholesterol, LDL cholesterol, and triglycerides), uric acid, and HbA1c (a biomarker of glycemic control) in the context of chronic kidney disease (CKD).
Who was studied?
A total of 149 men and women (average ages of 46–61) with CKD.
How was it studied?
A meta-analysis of 4 prospective observational studies was performed. The studies were conducted in the United Arab Emirates, Saudi Arabia, and India between 2019 and 2015. In all the studies, the participants fasted for 30 days in the month of Ramadan.
What were the results?
Ramadan fasting was not associated with changes in any of the outcomes studied.
All the studies included in the meta-analysis were of good methodological quality.
This Study Summary was published on June 17, 2024.